thursday

18

May
2017

PLENARY TALK III: Belgian life sciences: positioning from a European & Global perspective

View full programme

Nathalie Van den Haute - Director Corporate Finance, KBC Securities

Biography of the speaker:

Nathalie Van Den Haute joined the Corporate Finance department of KBC Securities, after obtaining a Masters in Financial Management at the Vlerick Management School. In 2004, she graduated as a Commercial Engineer at the University of Brussels – Solvay Management School.

Over the past years, Nathalie has been involved in several ECM and M&A transactions. She has developed a close affinitiy with the biotech and pharma sector through numerous ECM transactions such as the IPO of Movetis, Ablynx, arGEN-X and Biocartis and the SPO and ABO’s of Ablynx and Tigenix. Other selected  ECM transaction experience includes the IPOs of bpost, Nyrstar and Metris and the rights issue of Elia, Agfa-Gevaert, Nyrstar and Montea. On the M&A side Nathalie has worked on the buy- and sell-side. Nathalie has also worked also on several valuation assignments and independent expert reports.

PLATINUM SPONSORS

No Platinum sponsor yet.
Click here and become the first Platinum sponsor.

Gold sponsors

Silver sponsors